Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1990-12-7
pubmed:abstractText
Anti-Tac(Fv)-PE40 is a recombinant single-chain immunotoxin containing the heavy and light variable regions of the anti-Tac monoclonal antibody fused to a mutant form of Pseudomonas exotoxin (PE). Anti-Tac binds to the p55 subunit of the human interleukin 2 (IL-2) receptor, and anti-Tac(Fv)-PE40 kills human or monkey cell lines that contain either the intact IL-2 receptor or its p55 subunit alone. To assess the usefulness of anti-Tac(Fv)-PE40 in treatment of IL-2 receptor-positive leukemia, we tested peripheral blood mononuclear cells from six patients with adult T-cell leukemia. In each of the six patients, anti-Tac(Fv)-PE40 was extremely cytotoxic to the malignant cells. Metabolic activity and sensitivity of the fresh cells improved when a small amount of IL-2 (10 units per ml) was present during incubation. The toxin concentration necessary to inhibit protein synthesis by 50% after 16-hr incubation of cells with immunotoxin varied from 1.6 to 16 ng/ml (2.5-25 x 10(-11) M). In every case, binding was by means of the Tac antigen because anti-Tac(Fv)-PE40 cytotoxicity was prevented by adding excess anti-Tac antibody. Moreover, anti-Tac alone or an inactive mutant of anti-Tac(Fv)-PE40 without ADP-ribosylation activity had very little cytotoxic activity. Peripheral blood mononuclear cells from normal controls, from a patient with Tac-negative leukemia, and from adult T-cell leukemia patients without significant peripheral blood involvement were not sensitive to anti-Tac(Fv)-PE40. These results indicate that anti-Tac(Fv)-PE40 is a potent cytotoxin against adult T-cell leukemia cells in vitro and warrants clinical testing.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2118522, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2467293, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2498664, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2510169, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2786749, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2885323, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2986744, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3098436, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3132465, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3143716, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3283735, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6261256, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6602943, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6970774, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6979048
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8291-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:2236041-ADP Ribose Transferases, pubmed-meshheading:2236041-Antibodies, Monoclonal, pubmed-meshheading:2236041-Antigens, CD, pubmed-meshheading:2236041-Bacterial Toxins, pubmed-meshheading:2236041-Cell Line, pubmed-meshheading:2236041-Cell Survival, pubmed-meshheading:2236041-Exotoxins, pubmed-meshheading:2236041-Female, pubmed-meshheading:2236041-Humans, pubmed-meshheading:2236041-Immunoglobulin Variable Region, pubmed-meshheading:2236041-Immunotoxins, pubmed-meshheading:2236041-Leukemia, T-Cell, pubmed-meshheading:2236041-Leukemia-Lymphoma, Adult T-Cell, pubmed-meshheading:2236041-Leukocytes, Mononuclear, pubmed-meshheading:2236041-Male, pubmed-meshheading:2236041-Pseudomonas, pubmed-meshheading:2236041-Tumor Cells, Cultured, pubmed-meshheading:2236041-Virulence Factors
pubmed:year
1990
pubmed:articleTitle
The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
pubmed:affiliation
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
pubmed:publicationType
Journal Article